AAV capsid vehicles for molecular transfer
AssigneeUniversity of Pittsburgh
InventorsRichard Jude Samulski, Forrest K. Ferrari
Life of this patent
Estimating the term…
Abstract
The invention relates to the production of AAV capsids which may be used to transfer native or heterologous molecules into appropriate host cells. The capsid proteins can be expressed from a recombinant virus, expression vector, or from a cell line that has stably integrated the AAV capsid genes or coding sequences. The invention further provides for the production of AAV capsids in vitro from the AAV capsid proteins and the construction of packaged capsids in vitro. The invention further provides for the production of AAV capsids that have been genetically engineered to express heterologous epitopes of clinically important antigens to elicit an immune response.
Claims3
A method for transferring a molecule into a cell, comprising contacting the cell with an adeno-associated virus capsid vehicle in which a heterologous RNA molecule is covalently linked, bound to, or encapsidated, with adeno-associated virus capsid proteins.
A method for transferring a molecule into a cell, comprising contacting the cell with an adeno-associated virus capsid vehicle in which a heterologous protein is covalently linked, bound to, or encapsidated, with adeno-associated virus capsid proteins.
A method for transferring a molecule into a cell, comprising contacting the cell with an adeno-associated virus capsid vehicle in which a heterologous peptide is covalently linked, bound to, or encapsidated, with adeno-associated virus capsid proteins.
Dependencies are inferred from the claim text.